scispace - formally typeset
Open AccessJournal ArticleDOI

Global Epidemiology of Campylobacter Infection

Reads0
Chats0
TLDR
Overall, campylobacteriosis is still one of the most important infectious diseases that is likely to challenge global health in the years to come.
Abstract
Campylobacter jejuni infection is one of the most widespread infectious diseases of the last century. The incidence and prevalence of campylobacteriosis have increased in both developed and developing countries over the last 10 years. The dramatic increase in North America, Europe, and Australia is alarming, and data from parts of Africa, Asia, and the Middle East indicate that campylobacteriosis is endemic in these areas, especially in children. In addition to C. jejuni, there is increasing recognition of the clinical importance of emerging Campylobacter species, including Campylobacter concisus and Campylobacter ureolyticus. Poultry is a major reservoir and source of transmission of campylobacteriosis to humans. Other risk factors include consumption of animal products and water, contact with animals, and international travel. Strategic implementation of multifaceted biocontrol measures to reduce the transmission of this group of pathogens is paramount for public health. Overall, campylobacteriosis is still one of the most important infectious diseases that is likely to challenge global health in the years to come. This review provides a comprehensive overview of the global epidemiology, transmission, and clinical relevance of Campylobacter infection.

read more

Citations
More filters
Journal ArticleDOI

Guillain-Barré syndrome.

TL;DR: The data for GBS suggests that the immunologic mechanism can involve molecular mimicry, at least in some GBS variants, and it is likely that multiple mechanisms render the axon vulnerable.
Journal ArticleDOI

In Vitro Antimicrobial Activity of Green Synthesized Silver Nanoparticles Against Selected Gram-negative Foodborne Pathogens.

TL;DR: It is indicated that AgNPs exhibit a strong antimicrobial activity and thus might be developed as a new type of antimicrobial agents for the treatment of bacterial infection including multidrug resistant bacterial infection.
Journal ArticleDOI

Animals as sources of food-borne pathogens: A review

TL;DR: The evidence that links animals as vehicles of the foodborne pathogens Salmonella, Campylobacter, Shiga toxigenic E. coli, and L. monocytogenes, their impact, and their current status is reviewed.
Journal ArticleDOI

Campylobacteriosis: the role of poultry meat.

TL;DR: Overall, poultry is an important reservoir and source of human campylobacteriosis, although the contribution of other sources, reservoirs and transmission warrants more research.
Journal ArticleDOI

Campylobacteriosis, Salmonellosis, Yersiniosis, and Listeriosis as Zoonotic Foodborne Diseases: A Review

TL;DR: The aim of the paper is to summarize and provide information on campylobacteriosis, salmonellosis, yersiniosis, and listeriosis and the aetiological factors of those diseases, along with the general characteristics of pathogens, virulence factors, and reservoirs.
References
More filters
Journal ArticleDOI

Axonal Guillain-Barré syndrome: concepts and controversies

TL;DR: Improved understanding of the disease mechanism and pathophysiology might lead to new treatment options and improve the outlook for patients with AMAN.
Journal ArticleDOI

Campylobacter jejuni Is Not Merely a Commensal in Commercial Broiler Chickens and Affects Bird Welfare

TL;DR: Modern rapidly growing chicken breeds used in intensive production systems have a strong inflammatory response to C. jejuni infection that can lead to diarrhea, which, in turn, leads to damage to the feet and legs on the birds due to standing on wet litter.
Journal ArticleDOI

Estimating foodborne gastroenteritis, Australia.

TL;DR: An estimated 4.0–6.9 million episodes of foodborne gastroenteritis occur in Australia each year, according to the Australian Bureau of Statistics.
Journal ArticleDOI

Antimicrobial Resistance Mechanisms among Campylobacter

TL;DR: During the past few decades an increasing number of resistant Campylobacter isolates have developed resistance to fluoroquinolones and other antimicrobials such as macrolides, aminoglycosides, and beta-lactams.
Related Papers (5)